National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases (Q39392796)

11 September 2017

title

National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases (English)

1 reference

11 September 2017

0 references

3

M Kundi

1 reference

11 September 2017

H Kollaritsch

7

0 references

Heinz Burgmann

object named as

H Burgmann

4

0 references

author name string

P Rendi-Wagner

1

1 reference

11 September 2017

M Paulke-Korinek

2

1 reference

11 September 2017

A Georgopoulos

5

1 reference

11 September 2017

A Vécsei

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

3 May 2009

1 reference

11 September 2017

1 reference

11 September 2017

volume

27

1 reference

11 September 2017

issue

30

1 reference

11 September 2017

page(s)

3963-3968

1 reference

Burden of paediatric invasive pneumococcal disease in Europe, 2005.

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Pneumococcal disease surveillance in Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Pneumococcal conjugate vaccines--a European perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Macrolide resistance among invasive Streptococcus pneumoniae isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Childhood invasive pneumococcal disease in Germany between 1997 and 2003: Variability in incidence and serotype distribution in absence of general pneumococcal conjugate vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

MBL genotype and risk of invasive pneumococcal disease: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Pneumococcal disease in a paediatric population in a hospital of central Italy: a clinical and microbiological case series from 1992 to 2006.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

Characterisation of invasive pneumococcal isolates in Catalan children up to 5 years of age, 1989-2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.04.044

10.1016/J.VACCINE.2009.04.044

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference